Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
TORSKAL logo — 🌿 Green nanoparticles for cancer therapy

TORSKAL

🌿 Green nanoparticles for cancer therapy

Founded 2015 Reunion Reunion 4 employees

General Information

Company Name TORSKAL
Founded Year 2015
Location Reunion Reunion +1
Employees 4
Social

Get notified when TORSKAL moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About TORSKAL

TORSKAL is an international biotech/medtech company, a pioneer of green nanotechnology. We design disruptive gold nanoparticles for cancer therapy from green chemistry. We are committed to the development of a new generation of non-toxic and eco-friendly nanomaterials for the treatment of surface and deep cancers by green chemistry. We have discovered an innovative, green, and patented way of producing gold nanoparticles, leveraging Indian Ocean endemic plants, that have many applications in health. Main project: the Nanotheranostics Project (NT1), a treatment for skin cancer using near-infrared (IR) radiation-induced plasmonic phototherapy Deep Cancer program (NT2 & NT3), which aims to develop new nanotheranostics for the treatment of deep cancers such as prostate, bladder and pancreatic cancers We also sell our unique gold nanoparticles through our website's e-commerce platform which has a wide range of applications in diagnostics, research, industry, and others. TORSKAL is currently located in Europe (France, La Réunion) & China

No funding data available for TORSKAL yet.

Get notified when TORSKAL raises funding

TORSKAL Alternatives & Competitors

TORSKAL vs
Cello Therapeutics, Inc.
Cello Therapeutics, Inc. United States

Cello Therapeutics, Inc. (Cello) was founded in April 2016 and specializes in the development of nan...

Series Unknown
10 employees
Biotechnology, Health Care
TORSKAL vs
Sona Nanotech Inc.
Sona Nanotech Inc. Canada

Biocompatible Nanoparticle Technology Being Used to Develop Cancer Therapies & Rapid Diagnostics (CS...

Grant
14 employees
Biotechnology
TORSKAL vs
Ora Lee Smith Cancer Research Foundation
Ora Lee Smith Cancer Research Foundation United States

We are moving BEYOND HOPE to change the way cancer is treated!

12 employees
Health Care

FAQ About TORSKAL

🌿 Green nanoparticles for cancer therapy
TORSKAL was founded in 2015.
TORSKAL is headquartered in Reunion.
TORSKAL has approximately 4 employees.
Top alternatives and competitors to TORSKAL include Cello Therapeutics, Inc., Sona Nanotech Inc., Ora Lee Smith Cancer Research Foundation, Oncobox, Imagion Biosystems, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TORSKAL and Cello Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors TORSKAL and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy